Pharmaceutical - Actos, Pioglitazone

Filter

Current filters:

ActosPioglitazone

Popular Filters

Prior CHMP positive benefit-risk for pioglitazone confirmed; EMA starts NSAIDS review

24-10-2011

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has clarified its…

ActosDiabetesEuropeNeurologicalPharmaceuticalPioglitazoneRegulationTakeda Pharmaceuticals

Back to top